BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2617584)

  • 1. Binding of oxamniquine to the DNA of schistosomes.
    Pica-Mattoccia L; Cioli D; Archer S
    Trans R Soc Trop Med Hyg; 1989; 83(3):373-6. PubMed ID: 2617584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of schistosomes to hycanthone and oxamniquine.
    Cioli D; Pica-Mattoccia L; Archer S
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():38-45. PubMed ID: 2638729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on the mode of action of oxamniquine and related schistosomicidal drugs.
    Pica-Mattoccia L; Cioli D
    Am J Trop Med Hyg; 1985 Jan; 34(1):112-8. PubMed ID: 3838223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Schistosoma mansoni: hycanthone/oxamniquine resistance is controlled by a single autosomal recessive gene.
    Cioli D; Pica-Mattoccia L; Moroni R
    Exp Parasitol; 1992 Dec; 75(4):425-32. PubMed ID: 1493874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schistosoma mansoni: genetic complementation analysis shows that two independent hycanthone/oxamniquine-resistant strains are mutated in the same gene.
    Pica-Mattoccia L; Dias LC; Moroni R; Cioli D
    Exp Parasitol; 1993 Dec; 77(4):445-9. PubMed ID: 8253157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of tritiated hycanthone and hycanthone N-methylcarbamate to macromolecules of drug-sensitive and drug-resistant schistosomes.
    Pica-Mattoccia L; Cioli D; Archer S
    Mol Biochem Parasitol; 1988 Oct; 31(1):87-96. PubMed ID: 3185615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hycanthone resistance in schistosomes correlates with the lack of an enzymatic activity which produces the covalent binding of hycanthone to parasite macromolecules.
    Pica-Mattoccia L; Archer S; Cioli D
    Mol Biochem Parasitol; 1992 Oct; 55(1-2):167-75. PubMed ID: 1435868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation between schistosomicidal and anticholinergic properties of hycanthone and related drugs.
    Pica-Mattoccia L; Cioli D
    J Parasitol; 1986 Aug; 72(4):531-9. PubMed ID: 3783347
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on some derivatives of oxamniquine.
    el-Hamouly W; Pica-Mattoccia L; Cioli D; Schwartz HM; Archer S
    J Med Chem; 1988 Aug; 31(8):1629-31. PubMed ID: 3398000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic complementation analysis of two independently isolated hycanthone-resistant strains of Schistosoma mansoni.
    Pica-Mattoccia L; Dias LC; Cioli D
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 4():211-4. PubMed ID: 1343897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experimentally produced resistance of Schistosoma mansoni to hycanthone.
    Jansma WB; Rogers SH; Liu CL; Bueding E
    Am J Trop Med Hyg; 1977 Sep; 26(5 Pt 1):926-36. PubMed ID: 907054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake of [14C]oxamniquine by Schistosoma mansoni.
    Woolhouse NM; Kaye B
    Parasitology; 1977 Aug; 75(1):111-8. PubMed ID: 593728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections.
    Pica-Mattoccia L; Novi A; Cioli D
    Parasitol Res; 1997; 83(7):687-9. PubMed ID: 9272559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of in vitro RNA synthesis by hycanthone, oxamniquine and praziquantel.
    Wong LJ; Tsao GC; Bruce JI; Wong SS
    Experientia; 1990 May; 46(5):461-4. PubMed ID: 1693342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative study on the genetic effects of hycanthone and oxamniquine.
    Ray VA; Holden HE; Ellis JH; Hyneck ML
    J Toxicol Environ Health; 1975 Nov; 1(2):211-7. PubMed ID: 1107579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for the mode of antischistosomal action of hycanthone.
    Cioli D; Pica-Mattoccia L; Rosenberg S; Archer S
    Life Sci; 1985 Jul; 37(2):161-7. PubMed ID: 4010473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the treatment of mansoni schistosomiasis with oxamniquine.
    Pedro RD; Dias LC; Amato Neto V; De Carvalho SA
    Rev Bras Pesqui Med Biol; 1979 Jun; 12(2-3):207-11. PubMed ID: 515473
    [No Abstract]   [Full Text] [Related]  

  • 18. [Genetic and molecular aspects of drug resistance in Schistosoma mansoni].
    Pica L; Cioli D
    Ann Ist Super Sanita; 1986; 22(1):153-5. PubMed ID: 3752792
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of hycanthone administered in vivo upon the incorporation of radioactive precursors into macromolecules of Schistosoma mansoni.
    Pica Mattoccia L; Cioli D
    Mol Biochem Parasitol; 1983 Jun; 8(2):99-107. PubMed ID: 6192338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response of drug resistant isolates of Schistosoma mansoni to antischistosomal agents.
    Drescher KM; Rogers EJ; Bruce JI; Katz N; Dias LC; Coles GC
    Mem Inst Oswaldo Cruz; 1993; 88(1):89-95. PubMed ID: 8246759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.